These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8567994)

  • 1. Relation between stage, grade, proliferation, and expression of p53 and CD44 in adenomas and carcinomas of the colorectum.
    Jackson PA; Green MA; Pouli A; Hubbard R; Marks CG; Cook MG
    J Clin Pathol; 1995 Dec; 48(12):1098-101. PubMed ID: 8567994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of mdm2 and p53 in epithelial neoplasms of the colorectum.
    Hao XP; Günther T; Roessner A; Price AB; Talbot IC
    Mol Pathol; 1998 Feb; 51(1):26-9. PubMed ID: 9624416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferation and apoptosis in proliferative lesions of the colon and rectum.
    Kikuchi Y; Dinjens WN; Bosman FT
    Virchows Arch; 1997 Aug; 431(2):111-7. PubMed ID: 9293892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectal adenocarcinomas.
    Kanavaros P; Stefanaki K; Valassiadou K; Vlachonikolis J; Mavromanolakis M; Vlychou M; Kakolyris S; Gorgoulis V; Tzardi M; Georgoulias V
    Med Oncol; 1999 Apr; 16(1):23-30. PubMed ID: 10382939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis.
    Mulder JW; Wielenga VJ; Polak MM; van den Berg FM; Adolf GR; Herrlich P; Pals ST; Offerhaus GJ
    Gut; 1995 Jan; 36(1):76-80. PubMed ID: 7534253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and clinicopathologic significance of TUFM and p53 for the normal-adenoma-carcinoma sequence in colorectal epithelia.
    Xi HQ; Zhang KC; Li JY; Cui JX; Zhao P; Chen L
    World J Surg Oncol; 2017 Apr; 15(1):90. PubMed ID: 28449687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance.
    Baretton GB; Diebold J; Christoforis G; Vogt M; Müller C; Dopfer K; Schneiderbanger K; Schmidt M; Löhrs U
    Cancer; 1996 Jan; 77(2):255-64. PubMed ID: 8625232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular markers are predictors of recurrence and survival in patients with Dukes B and Dukes C colorectal adenocarcinoma.
    Bhatavdekar JM; Patel DD; Chikhlikar PR; Shah NG; Vora HH; Ghosh N; Trivedi TI
    Dis Colon Rectum; 2001 Apr; 44(4):523-33. PubMed ID: 11330579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial neoplasms of the appendix and colorectum: an analysis of cell proliferation, apoptosis, and expression of p53, CD44, bcl-2.
    Carr NJ; Emory TS; Sobin LH
    Arch Pathol Lab Med; 2002 Jul; 126(7):837-41. PubMed ID: 12088454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of bcl-2 and p53 oncoproteins: correlation with Ki67 proliferation index and prognostic histopathologic parameters in colorectal neoplasia.
    Saleh HA; Jackson H; Banerjee M
    Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):175-82. PubMed ID: 10981868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors.
    Kusaba T; Nakayama T; Yamazumi K; Yakata Y; Yoshizaki A; Nagayasu T; Sekine I
    J Clin Pathol; 2005 Aug; 58(8):833-8. PubMed ID: 16049285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Bcl-2 and p53 in the colorectal adenoma-carcinoma sequence.
    Hao XP; Ilyas M; Talbot IC
    Pathobiology; 1997; 65(3):140-5. PubMed ID: 9309780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of endoscopic biopsy using immunostaining of p53 and Ki-67 in tumors of the ampulla of Vater.
    Kubota K; Kakuta Y; Kawamura S; Saito S; Seki H; Kuniyoshi T
    Pathol Int; 2003 Jun; 53(6):361-70. PubMed ID: 12787310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of p53 protein and histologic grades of dysplasia in colorectal adenomas.
    Sameshima S; Kubota Y; Sawada T; Watanabe T; Kuroda T; Tsuno N; Higuchi Y; Shinozaki M; Sunouchi K; Masaki T; Saito Y; Muto T
    Dis Colon Rectum; 1996 May; 39(5):562-7. PubMed ID: 8620809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 Protein overexpression in colorectal tumors from patients with familial adenomatous polyposis: is it an early or late event?
    Levi E; Stryker SJ; Rao MS
    Am J Gastroenterol; 1996 Jan; 91(1):11-4. PubMed ID: 8561108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of CD44: a useful independent predictor of prognosis in patients with colorectal carcinomas.
    Bhatavdekar JM; Patel DD; Chikhlikar PR; Trivedi TI; Gosalia NM; Ghosh N; Shah NG; Vora HH; Suthar TP
    Ann Surg Oncol; 1998 Sep; 5(6):495-501. PubMed ID: 9754757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic evaluation of metallothionein expression in human colorectal neoplasms.
    Ioachim EE; Goussia AC; Agnantis NJ; Machera M; Tsianos EV; Kappas AM
    J Clin Pathol; 1999 Dec; 52(12):876-9. PubMed ID: 10711249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 and CD44 as clinical markers of tumour progression in colorectal carcinogenesis.
    Mulder JW; Wielenga VJ; Pals ST; Offerhaus GJ
    Histochem J; 1997 Jun; 29(6):439-52. PubMed ID: 9248852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 expression in colorectal tumors.
    Purdie CA; O'Grady J; Piris J; Wyllie AH; Bird CC
    Am J Pathol; 1991 Apr; 138(4):807-13. PubMed ID: 1707233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imbalance between proliferation and apoptosis in the development of colorectal carcinoma.
    Hao X; Du M; Bishop AE; Talbot IC
    Virchows Arch; 1998 Dec; 433(6):523-7. PubMed ID: 9870685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.